A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 78.09 USD 1.02%
Market Cap: 5.3B USD

Wall Street
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 99.45 USD with a low forecast of 70.7 USD and a high forecast of 121.8 USD.

Lowest
Price Target
70.7 USD
9% Downside
Average
Price Target
99.45 USD
27% Upside
Highest
Price Target
121.8 USD
56% Upside
Apogee Therapeutics Inc Competitors:
Price Targets
PHM
Pharma Mar SA
30% Upside
ABBV
Abbvie Inc
9% Upside
688382
InventisBio Co Ltd
73% Upside
KURA
Kura Oncology Inc
217% Upside
COV
Covalon Technologies Ltd
71% Upside
688331
RemeGen Co Ltd
18% Upside
300896
Imeik Technology Development Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APGE's stock price target?
Price Target
99.45 USD

According to Wall Street analysts, the average 1-year price target for APGE is 99.45 USD with a low forecast of 70.7 USD and a high forecast of 121.8 USD.

Back to Top